Open Access

Clinical utility of the Xpert MRSA assay for early detection of methicillin-resistant Staphylococcus aureus

  • Authors:
    • Ae-Chin Oh
    • Jin Kyung Lee
    • Ha Na Lee
    • Young Jun Hong
    • Yoon Hwan Chang
    • Seok-Il Hong
    • Dong Ho Kim
  • View Affiliations

  • Published online on: October 9, 2012     https://doi.org/10.3892/mmr.2012.1121
  • Pages: 11-15
  • Copyright: © Oh et al. This is an open access article distributed under the terms of Creative Commons Attribution License [CC BY_NC 3.0].

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Abstract

Methicillin-resistant Staphylococcus aureus (MRSA) is responsible for many nosocomial and community-acquired infections, resulting in significant morbidity and mortality. A practical way to limit the spread of MRSA is early detection and proper treatment. However, screening culture for MRSA typically requires 2-3 days. The Xpert MRSA assay (Cepheid, Sunnyvale, CA, USA) is a real-time polymerase chain reaction-based assay developed for screening an MRSA-specific DNA sequence within the staphylococcal cassette chromosome in 2 h. Lower respiratory tract specimens, such as transtracheal aspirates (TTAs) and bronchoalveolar lavage fluid (BALF), are commonly obtained from intubated patients. Therefore, using the lower respiratory tract specimens with the Xpert MRSA assay may be a practical tool for patient care. We performed the Xpert MRSA assay on 108 TTA and 21 BALF specimens from 92 patients and compared the results to those obtained by culture. The two assays showed concordant results in 120 (93.0%) cases and discordant results in 9 (7.0%) cases, which were culture‑negative and Xpert MRSA-positive. Among the discordant cases, 5 patients developed culture-positive samples 2-15 days after the Xpert MRSA detected MRSA. We conclude that the Xpert MRSA assay is a rapid, sensitive and clinically useful test, particularly for the early detection of MRSA.
View References

Related Articles

Journal Cover

January 2013
Volume 7 Issue 1

Print ISSN: 1791-2997
Online ISSN:1791-3004

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
x
Spandidos Publications style
Oh A, Lee JK, Lee HN, Hong YJ, Chang YH, Hong S and Kim DH: Clinical utility of the Xpert MRSA assay for early detection of methicillin-resistant Staphylococcus aureus. Mol Med Rep 7: 11-15, 2013
APA
Oh, A., Lee, J.K., Lee, H.N., Hong, Y.J., Chang, Y.H., Hong, S., & Kim, D.H. (2013). Clinical utility of the Xpert MRSA assay for early detection of methicillin-resistant Staphylococcus aureus. Molecular Medicine Reports, 7, 11-15. https://doi.org/10.3892/mmr.2012.1121
MLA
Oh, A., Lee, J. K., Lee, H. N., Hong, Y. J., Chang, Y. H., Hong, S., Kim, D. H."Clinical utility of the Xpert MRSA assay for early detection of methicillin-resistant Staphylococcus aureus". Molecular Medicine Reports 7.1 (2013): 11-15.
Chicago
Oh, A., Lee, J. K., Lee, H. N., Hong, Y. J., Chang, Y. H., Hong, S., Kim, D. H."Clinical utility of the Xpert MRSA assay for early detection of methicillin-resistant Staphylococcus aureus". Molecular Medicine Reports 7, no. 1 (2013): 11-15. https://doi.org/10.3892/mmr.2012.1121